
Variational AI
Executives
7Variational AI Management Team
7 Team Members
Variational AI has 7 executives. Variational AI's current Founder, Chief Executive Officer is Handol Kim.
Name | Work History | Title | Status |
|---|---|---|---|
Handol Kim | Teradici, Red Bend Software, Intrinsyc Software International, D-Wave Systems, Microdisplay Corporation, Coradiant, and Global Affairs Canada | Founder, Chief Executive Officer | Current |
Name | Handol Kim | ||||
|---|---|---|---|---|---|
Work History | Teradici, Red Bend Software, Intrinsyc Software International, D-Wave Systems, Microdisplay Corporation, Coradiant, and Global Affairs Canada | ||||
Title | Founder, Chief Executive Officer | ||||
Status | Current |
Compare Variational AI to Competitors

InstaDeep focuses on delivering artificial intelligence (AI)-powered decision-making systems for various enterprise sectors. The company offers solutions that leverage computing, deep learning, and reinforcement learning to address challenges in industries such as biology, logistics, electronic design, and energy. Its products and services are designed to help the capabilities of businesses by providing advanced AI tools and research insights. InstaDeep was formerly known as Digital Ink Group. It was founded in 2014 and is based in London, United Kingdom.

Cradle focuses on protein engineering in the biotechnology sector, using machine learning to optimize protein sequences. It provides tools for designing improved variants of target proteins, integrating laboratory data, and predicting performance to support research and development. Its solutions are relevant for biotech teams working on various applications, including therapeutics, enzymes, vaccines, peptides, and antibodies. It was founded in 2021 and is based in Amsterdam, Netherlands.

Aqemia focuses on transforming the drug discovery process. The company offers technology that combines quantum-inspired physics and machine learning to scale the drug discovery process, generating a rapidly growing pipeline of new drug candidates. It primarily sells to the pharmaceutical industry. It was founded in 2019 and is based in Paris, France.

Insilico Medicine focuses on artificial intelligence in drug discovery and development. The company provides artificial intelligence platforms for multi-omics target discovery, deep biology analysis, automated drug design, and predicting outcomes in clinical trials. The technologies are intended to assist in the process of discovering and developing new medications for various diseases. It was founded in 2014 and is based in New Territories, Hong Kong.
YDS Pharmatech is a company focused on drug discovery in the pharmaceutical industry. The company offers a platform for the design of new drug candidates, utilizing structure-based de novo drug design and evolutionary AI to accelerate the drug discovery process. YDS Pharmatech primarily serves the pharmaceutical industry. It was founded in 2020 and is based in Albany, New York.

Endel specializes in creating personalized sound environments designed to reduce stress, improve sleep, and enhance productivity, utilizing neuroscience and circadian rhythm science. The company offers a range of products, including apps for iOS and Android, integrations with Alexa, and a standalone Apple Watch app, all featuring adaptive soundscapes that respond to real-time inputs such as time of day, weather, and heart rate. It was founded in 2018 and is based in Berlin, Germany.
Loading...

